Lab-testing startup uBiome lays off half of global workforce

While under investigation for its billing practices, lab-testing startup uBiome laid off half of its global workforce July 10, according to The Wall Street Journal.

Interim CEO Curtis Solsvig, also a director at consulting firm Goldin Associates, informed employees July 10 about the layoffs. Around 114 positions of a total 229 worldwide were affected. This included 42 U.S. jobs and 72 in Latin America, a person close with the matter told WSJ.

High-ranking operational executives were included in the layoffs, including uBiome's COO Nat Walton, former employees told WSJ. The company's lab director Susan Zneimer was laid off along with all three employees who worked at the new lab in Vancouver, Wash., former employees confirmed.

UBiome will not close its San Francisco lab; however, it is unclear who will serve as the lab's director.

More articles on healthcare innovation:
Geisinger developing AI solutions to detect, prevent high-burden diseases
Eisai launches startup incubator for genomics-driven dementia research
Atrium Health integrates app for virtual pregnancy care

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers